Skip to main content

From Psych Congress and Psych Congress Regionals

Mood Disorders

Introducing time-limited adaptive stressors has demonstrated a profound effect on patient well-being, but efforts to sidestep stress often overshadow these approaches in today's society, Psych…
Psych Congress 2020 speaker Joseph F. Goldberg, MD, details factors that could influence a patient's response to a treatment for bipolar disorder, and how clinicians can address them.
A pharmacogenomic test was associated with improved outcomes in patients with major depressive disorder who failed to improve with previous antidepressant treatment, according to a meta-analysis…
A secondary analysis of a study investigating adjunctive pimavanserin for the treatment of patients with major depressive disorder found that it significantly improved insomnia and sleepiness,…
In managing side effects associated with psychotropic drugs, prescribers need to arm themselves with a menu of strategies and opt first for simpler solutions over adding or switching a medication,…
Patients with major depressive disorder had significantly lower odds of filling a written prescription for a new antidepressant if they were nonwhite and antidepressant-naïve, according to an…
Up to 2 years of treatment with lurasidone improved manic symptoms in children and adolescents with bipolar depression, according to a poster presented at Psych Congress 2020.
Many women experience an even greater vulnerability to psychiatric crisis in the postpartum period than during pregnancy, requiring a careful balancing of needs that should prioritize the mother's…
Clinicians could be on the brink of a much greater understanding of the relatively new diagnosis of disruptive mood dysregulation disorder (DMDD) in children, including evidence on the most promising…
The use of psychedelics in psychotherapy can help patients go beyond ameliorating symptoms and confront their root causes of depression, Andrew D. Penn, RN, MS, NP, CNS, APRN-BC, and Charles Raison,…
Back to Top